REPORTS

Let’s Pullulate and Expand Your Business

Paediatric Vaccine Market - Global Professional Analysis and Forecast to 2026

Oct 22, 2019  |  204 PAGES  |  REPORT CODE: CMM220881
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Paediatric Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.3% during the forecast period.

This report presents the market size and development trends by detailing the Paediatric Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Paediatric Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Paediatric Vaccine industry and will help you to build a panoramic view of the industrial development.

Paediatric Vaccine Market, By Type:

  • Monovalent Vaccine

  • Multivalent Vaccine

Paediatric Vaccine Market, By Application:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Institutional Health Centres

Some of the leading players are as follows:

  • Merck

  • GlaxoSmithKline

  • Zydua Cadila

  • Pfizer

  • Emergent BioSolutions

  • Pancea Biotec

  • Bharat Biotech

  • Indian Immunologicals

  • Sanofi

  • Serum Institute of India

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Paediatric Vaccine Market: Technology Type Analysis

  • 4.1 Paediatric Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Paediatric Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Monovalent Vaccine

    • 4.3.2 Multivalent Vaccine

5 Paediatric Vaccine Market: Product Analysis

  • 5.1 Paediatric Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Paediatric Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Paediatric Vaccine Market: Application Analysis

  • 6.1 Paediatric Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Paediatric Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital Pharmacies

    • 6.3.2 Retail Pharmacies

    • 6.3.3 Institutional Health Centres

7 Paediatric Vaccine Market: Regional Analysis

  • 7.1 Paediatric Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Paediatric Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Merck

    • 9.1.1 Merck Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 GlaxoSmithKline

    • 9.2.1 GlaxoSmithKline Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Zydua Cadila

    • 9.3.1 Zydua Cadila Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Pfizer

    • 9.4.1 Pfizer Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Emergent BioSolutions

    • 9.5.1 Emergent BioSolutions Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Pancea Biotec

    • 9.6.1 Pancea Biotec Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Bharat Biotech

    • 9.7.1 Bharat Biotech Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Indian Immunologicals

    • 9.8.1 Indian Immunologicals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Sanofi

    • 9.9.1 Sanofi Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Serum Institute of India

    • 9.10.1 Serum Institute of India Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 86 Figures and 150 Tables)

  • Figure Monovalent Vaccine Paediatric Vaccine market, 2015 - 2026 (USD Million)

  • Figure Multivalent Vaccine Paediatric Vaccine market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Institutional Health Centres market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Paediatric Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Paediatric Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Paediatric Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Paediatric Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Paediatric Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Paediatric Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Paediatric Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Paediatric Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zydua Cadila Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emergent BioSolutions Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pancea Biotec Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bharat Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Indian Immunologicals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top